Mettler-Toledo International, Inc. $MTD Shares Sold by Beacon Investment Advisory Services Inc.

Key Points

• Beacon Investment Advisory Services Inc. cut its stake in Mettler-Toledo International by 30.4%, leaving it with 14,669 shares valued at approximately $17.2 million.
• Insiders, including CFO Shawn Vadala and Director Thomas P. Salice, sold a total of 1,827 shares worth over $2.3 million in the last 90 days, indicating significant insider selling.
• Mettler-Toledo's stock has faced a 1.2% decline recently, with analysts projecting a consensus price target of $1,325.56 and a current average rating of "Moderate Buy".

Beacon Investment Advisory Services Inc. decreased its holdings in Mettler-Toledo International, Inc. (NYSE:MTD - Free Report) by 30.4% in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 14,669 shares of the medical instruments supplier's stock after selling 6,411 shares during the quarter. Beacon Investment Advisory Services Inc. owned about 0.07% of Mettler-Toledo International worth $17,232,000 as of its most recent SEC filing.

Other institutional investors have also recently made changes to their positions in the company. WPG Advisers LLC acquired a new stake in Mettler-Toledo International during the 1st quarter worth about $41,000. Zions Bancorporation National Association UT acquired a new stake in Mettler-Toledo International during the 1st quarter worth about $43,000. Golden State Wealth Management LLC lifted its position in Mettler-Toledo International by 583.3% during the 1st quarter. Golden State Wealth Management LLC now owns 41 shares of the medical instruments supplier's stock worth $48,000 after acquiring an additional 35 shares during the period. Menard Financial Group LLC acquired a new stake in Mettler-Toledo International during the 4th quarter worth about $67,000. Finally, Blue Trust Inc. lifted its position in Mettler-Toledo International by 520.0% during the 1st quarter. Blue Trust Inc. now owns 62 shares of the medical instruments supplier's stock worth $73,000 after acquiring an additional 52 shares during the period. Institutional investors and hedge funds own 95.07% of the company's stock.

Insider Activity at Mettler-Toledo International

In related news, CFO Shawn Vadala sold 300 shares of Mettler-Toledo International stock in a transaction dated Friday, August 8th. The stock was sold at an average price of $1,254.09, for a total value of $376,227.00. Following the completion of the transaction, the chief financial officer owned 5,095 shares in the company, valued at $6,389,588.55. The trade was a 5.56% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Thomas P. Salice sold 1,062 shares of Mettler-Toledo International stock in a transaction dated Wednesday, August 13th. The shares were sold at an average price of $1,300.90, for a total value of $1,381,555.80. Following the completion of the transaction, the director owned 283 shares of the company's stock, valued at approximately $368,154.70. This represents a 78.96% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 1,827 shares of company stock worth $2,371,208 in the last 90 days. Corporate insiders own 1.94% of the company's stock.

Mettler-Toledo International Stock Down 1.2%

Shares of Mettler-Toledo International stock opened at $1,241.91 on Thursday. Mettler-Toledo International, Inc. has a twelve month low of $946.69 and a twelve month high of $1,521.01. The business has a 50-day moving average price of $1,269.03 and a 200 day moving average price of $1,185.85. The firm has a market cap of $25.58 billion, a PE ratio of 31.45, a P/E/G ratio of 3.77 and a beta of 1.37.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last announced its quarterly earnings results on Thursday, July 31st. The medical instruments supplier reported $10.09 earnings per share for the quarter, beating the consensus estimate of $9.58 by $0.51. Mettler-Toledo International had a negative return on equity of 476.07% and a net margin of 21.46%.The firm had revenue of $983.22 million during the quarter, compared to analyst estimates of $957.41 million. During the same quarter in the previous year, the business earned $9.65 EPS. Mettler-Toledo International's revenue for the quarter was up 3.9% compared to the same quarter last year. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS. On average, sell-side analysts expect that Mettler-Toledo International, Inc. will post 42.71 EPS for the current year.

Wall Street Analysts Forecast Growth

MTD has been the subject of a number of research reports. Evercore ISI lowered their price target on Mettler-Toledo International from $1,280.00 to $1,275.00 and set an "outperform" rating for the company in a research report on Monday, August 4th. Bank of America lifted their price target on Mettler-Toledo International from $1,260.00 to $1,390.00 and gave the stock a "neutral" rating in a research report on Monday. Citigroup lifted their price objective on Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the company a "buy" rating in a research note on Thursday, August 21st. Barclays began coverage on Mettler-Toledo International in a research note on Tuesday, June 24th. They set an "overweight" rating and a $1,325.00 price objective for the company. Finally, Robert W. Baird lifted their price objective on Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the company a "neutral" rating in a research note on Monday, August 4th. Five research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the stock. According to data from MarketBeat, Mettler-Toledo International presently has an average rating of "Moderate Buy" and a consensus price target of $1,325.56.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.